Patent information
IP India · live recordApplication number
202317072936
Filing date
26 October 2023
Status
Application Awaiting Examination
Publication number
37/2024
Publication type
INA
Invention field
Chemical
Abstract
The present invention relates to a compound of formula (I) wherein A, Z, L, R1, R2, R3, R4, R5 and R33 are as defined in claim 1, or a pharmaceutically acceptable salt thereof. The compounds of formula (I) possess utility as inhibitors of TEAD. The compounds are useful as medicaments in the treatment of diseases or conditions wherein inhibition of TEAD is desired, such as cancer and chronic pain.
Applicants
1Finland
ORION CORPORATION
Orionintie 1
FI-02200 Espoo
Inventors
7Finland
AHLMARK, Markoc/o ORION CORPORATION
P.O.Box 65
FI-02101 Espoo
Finland
DIN BELLE, Davidc/o ORION CORPORATION
PO Box 65
FI-02101 Espoo
Finland
NOUTSIAS, Dimitrisc/o ORION CORPORATION
P.O.Box 65
FI-02101 Espoo
Finland
PIETIKÄINEN, Pekkac/o ORION CORPORATION
PO Box 65
FI-02101 Espoo
Finland
RUMMAKKO, Petteric/o ORION CORPORATION
P.O.Box 65
FI-02101 Espoo
Finland
SIPILÄ, Juliusc/o ORION CORPORATION
PO Box 65
FI-02101 Espoo
Germany
WOHLFAHRT, GerdChausseestrasse 121
10115 Berlin
Documents
Sign in to openApplication documents
1
202317072936-TRANSLATIOIN OF PRIOIRTY DOCUMENTS ETC. [26-10-2023(online)].pdf
26 Oct 2023
2
202317072936-STATEMENT OF UNDERTAKING (FORM 3) [26-10-2023(online)].pdf
26 Oct 2023
3
202317072936-FORM 1 [26-10-2023(online)].pdf
26 Oct 2023
4
202317072936-DECLARATION OF INVENTORSHIP (FORM 5) [26-10-2023(online)].pdf
26 Oct 2023
5
202317072936-COMPLETE SPECIFICATION [26-10-2023(online)].pdf
26 Oct 2023
6
202317072936-FORM-26 [03-01-2024(online)].pdf
03 Jan 2024
7
202317072936-Proof of Right [01-04-2024(online)].pdf
01 Apr 2024
8
202317072936-FORM 3 [01-04-2024(online)].pdf
01 Apr 2024
9
202317072936-FORM 18 [13-03-2025(online)].pdf
13 Mar 2025